Inhibition of nitric oxide synthesisduring bacterial shock in rodents doesnot prevent development of resistant(decompensated) hypotension and death
A.S. Khromov, I.V.Ivanova, A.V. Stefanov
Institute of Pharmacology and Toxicology, Academy ofMedical Sciences of Ukraine, Kyiv
Abstract
The study subject was the white rat-males Wistar after intra-
peritoneal injection of the mixture of St. aureus and B.
pyocyaneus daily cultures in the dose calculated as 1 milliard
microbial organisms of each species per 100 g b.w., as well as
the vascular preparations isolated from aortas of those rats.
The aim is to study nitric oxide role in the development of
resistant hypotension under generalization of the purulent
infection. Infection of the animals with a mixture of gram-
positive and gram-negative cultures led to the development of
the pathological process, which can be considered as a septic
(bacterial) shock. A primary lowering of the vascular tone
caused by depression of the myocardial pump and contractile
functions was observed. Injection of methylene blue or NOS
blockers (L-NAME, S-methyl-thiourea) to the infected animals
in the moment of hypotension development caused only a
short-term rise in blood pressure. Survival rate in such animals
was significantly lower compared to the control infected
animals. Repeated injections of those agents hastened death of
the experimental animals. The experiments in vitro revealed no
dilatory effect of acetylcholine with preserved sensitivity of
the vascular preparations to adrenomimetics and exogenous
nitric oxide in both control infected animals and animals injected
with methylene blue or NOS blockers. The data obtained
suggested that resistant hypertension in terminal stages of
septic shock is nitric oxide-independent.
References
- Брин В.Б., Зонис Б.Я. Физиология системногокровообращения. Формулы и расчеты. – Из-воРостов. ун-та, 1984. – 88 с.
- Лакин Г.Ф. Биометрия. – М.: Высш. школа, 1973. – 343 с.
- Хромов О.С. Вплив ліпіну на зміни системногокровообігу у спонтанно-гіпертензивних щурів //Ліки. – 2000. – №3–4. – С. 30–36.
- Хромов О.С., Соловйов А.І., Стефанов О.В.Моделювання ендотоксичного та септичного шокуу гризунів: Доклінічні дослідження лікарськихзасобів / За ред. О.В. Стефанова. – К.: Авіцена, 2001. –С.503–515.
- Avontuur J.A.M., Boomsma F., Van den MeirackerA.H. et al. Endothelin-1 and blood pressure after ofnitric oxide synthesis in human septic shock // Circulat. –1999. – 99. – P.271–275.
- Brady A.J. Nitric oxide, myocardial failure and septicshock (Review) // Int. J. Cardiol. – 1995. – 50. – P.269–272.
- Cochran J.B., Genovese F., Ogura S. et al. Effect ofnitric oxide donors and nitric oxide synthase inhibitorsin neonatal rat endotoxic shock // Biochem. Pharmacol. –1999. – 58. – P.687–691.
- Davies M.G., Fulton G.J. Haden P. Clinical biology ofnitrie oxide // Brit. J. Surg. – 1995. –82. – Р.1598–1610.
- 9. Gray G.A., Schott C., Julou-Schaeffer G. et al. Aninvestigation of the effects of inhibitors of the L-arginine pathway on endotoxin-induced vascularhyporeactivity in vivo // Brit. J. Pharmacol. – 1991. –103. – P.1218–1224.
- 10. Groeneveld A.B.J., Bronsveld W., Thijs L.G. Hemo-dynamic determinants of mortality in human septicshock// Surgery. – 1986. – 99. – P.140–152.
- Keaney J., Puynia J., Francis S. et al. Methylene bluereverses endotoxin induced hypotension // Circulat.Res. – 1994. – 74. – P.1121–1125.
- Kilbourne R.G., Gross S.S., Jubran A. et al. NG-Methyl-L-Arginine inhibits tumor necrosis factor-in-duced hypotension: implications for the involvementof nitric oxide // Proc. Natl. Acad. Sci. USA. – 1990. –87. – P.3629–3632.
- Kubichek W., Patterson R„ Witsce D. Impedance car-diography as a noninvasive method of monitoringcardial function and other parameters of cardiovasscu-lar system // Ann. N.Y. Acad. Sci. – 1970. – 170. – P.724–732.
- Mitaka C., Hirata Y., IchiKawa T. et al. Effect of nitricoxide synthase inhibitor on hemodynamic change andO2 delivery in septic dogs // Amer. J. Physiol. – 1995. –2, №5, Pt.2. – P.H2017–H2023.
- Nava E., Salazar F.J. Comparative effects of nitric ox-ide synthesis inhibitor and catecholamine treatment ina rat model of endotoxin shock // Eur. J. Clin. Invest. –1997. – 27. – P.673–679.
- Parker J.L., Myers P.R., Zhong I. Inhibition of endot-helium-dependet vasodilatation by Escherichia coliendotoxin // Shock. – 1994. – 2. – P.451–458.
- Parrillo J.E. Pathogenesis of cardiovascular dysfunctionin septic shock. – In: Update in intensive care andemergency medicine/ Ed. Vincent J.L. – Berlin–Heidenberg–New York: Springer, 1989. – 8. – P.317–321.
- Schoonover L.L., Stewart A.S., Clifton G.D. Hemody-namic and cardiovascular effects of nitric oxide modu-lation in the therapy of septic shock // Pharmaco-therapy. – 2000. – 20, №10. – P. 1184–1197.
- 19. Soloviev A., Stefanov А., Tishkin S., Khromov A. Sa-line containing phosphatidylcholine liposomes possessthe ability to restore endothelial function damaged re-sulting from g-irradiation // J. Physiol. Pharmacol. –2002. – 53, №3. – P.74–81.
- 20. Szabo C., Cuzzocrea S., Zingarelli B. et al. Endothelialdysfunction in a rat model of endotoxic shock – Importanceof the activation of poly (ADP-ribose) synthase byperoxynitrite // J. Clin. Invest. – 1997. – 100. – P.723–773.
- Szabo C., Salzman A.L., Ischiropoulos H. Endotoxin trig-the expression of an inducible isoform of nitric oxidesynthase and the formation of peroxynitrite in the rataorta in vivo // FEBS Lett. – 1995. –363. – P.235–238.
- Veragut P., Krayenbuhl H. Estimation and quatificationof myocardial contractility in the closed- chest dogs //Cardiologia. – 1965. – 47. – P.96–112.
- Wu C.C., Szabo C., Chen S.J. et al. Activation osoluble guanylyl cyclase by a factor other then nitricoxide or carbon monoxide contributes to the vascularhyporeactivity to vasoconstrictiors agents in the aortaof rats treated with endotoxin // Biochem. and Biophys.Res. Commun. – 1994. – 201. – P.436–442.
|